Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Psychotherapy, Multiple × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Low-grade Glioma 1 Carcinoma, Hepatocellular 1 Adenocarcinoma 1

Interventions

Oxaliplatin 42 Gemcitabine 38 Fluorouracil 36 Capecitabine 28 pembrolizumab 26 Leucovorin 25 Docetaxel 24 Cisplatin 22 Paclitaxel 18 Carboplatin 16 Radiotherapy 15 Bevacizumab 15 Pemetrexed 14 130-nm albumin-bound paclitaxel 14 Irinotecan 13 Nivolumab 11 Albumin-Bound Paclitaxel 11 Ramucirumab 9 Cyclophosphamide 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 durvalumab 5 Taxes 5 Sorafenib 5 S 1 (combination) 5 Metformin 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06238752 2024-02-02

RENMIN-213

Renmin Hospital of Wuhan University

Phase 2 Completed

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡